3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Multiple Myeloma
2
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Mesothelioma, Malignant
1
Melanoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Carcinoma, Squamous Cell
1
Interventions
neurotropin
1
haloperidol decanoate
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Temozolomide
1
Tadalafil
1
Surveys and Questionnaires
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nutritional Status
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Lorazepam
1
Interleukin 1 Receptor Antagonist Protein
1
Exercise Therapy
1
Exercise
1
Dexamethasone
1
Cyclophosphamide
1
Bendamustine Hydrochloride
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
In Situ Hybridization, Fluorescence
×
1 year
×
Clear all
No trials found.